No individuals were charged, and in victim impact statements Tuesday, many people objected to the negotiated sentence. "We still deserve jus
Oligarchs and CEO’s always manage to get away without being held accountable for their crimes.
😡

seen from United States
seen from United States
seen from South Korea
seen from United States
seen from Russia

seen from United States
seen from Romania
seen from United Kingdom

seen from United States
seen from Yemen
seen from China

seen from Russia
seen from United States
seen from Spain
seen from United Kingdom

seen from United Kingdom

seen from Türkiye
seen from Maldives
seen from Switzerland
seen from United States
No individuals were charged, and in victim impact statements Tuesday, many people objected to the negotiated sentence. "We still deserve jus
Oligarchs and CEO’s always manage to get away without being held accountable for their crimes.
😡
Frank Huntley looks at his sculpture made out of the opioid pill bottles he got when addicted. Photograph: Rick Wilking/Reuters
'Your actions are sickening': Sackler hearing inspires rare bipartisan disgust | Opioids crisis | The Guardian
Emerging from the shadows to address Purdue’s role in the opioid crisis, David and Kathe Sackler misjudged the mood
A company that proved that there’s no opiate for the masses like … opioids!
BREAKING: The Supreme Court has just ruled 5-4 that Purdue Pharma can't shield members of the Sackler family from liability for the opioid c
Victims of the opioid crisis confronted members of the Sackler family, the owners of major pharmaceutical manufacturer Perdue Pharma, in a hearing Thursday.
Purdue Pharma previously tried to declare bankruptcy in order to shield the Sackler Family from personal responsibility in the suit, a plan that was overturned by New York U.S. District Judge Colleen McMahon in December 2021. Judge McMahon said that providing the Sackler family with immunity from opioid-related lawsuits was “inconsistent” with U.S. Bankruptcy Code.
Overseeing the proceedings was Bankruptcy Judge Robert Drain, who said Wednesday that he would approve a plan to lock the Sackler family into providing an additional $1.2 billion to the national lawsuit settlement estimated to be worth up to $6 billion. The settlement could reach $10 billion over time, essentially turning Purdue into a public trust, according to the AP.
“The nature of today’s proceedings are unique and important,” Drain said as he opened the hearing Thursday, according to The AP. “The past and ongoing impact of OxyContin on individual people has always been of critical importance in this case.”
This is the first time families and victims were able to confront the Sackler family directly. The family was not permitted to respond to victim statements, the AP noted.
“When you created OxyContin, you created so much loss for so many people. … I’m outraged that you haven’t owned up to the crisis that you’ve created,” Kay Scarpone, mother of late retired marine Joseph Scarpone, told the family. Joseph died from his addiction one month before his 26th birthday, according to the outlet.
Scarpone’s mother was among one of roughly 24 people who spoke of the devastating impacts OxyContin had on them and their families, The outlet continued.
Richard Sackler has consistently maintained that Purdue and the Sackler family bear no responsibility for the opioid crisis, the outlet noted.
You can read the Daily Caller’s series on the opioid crisis and Sackler family, “American Cartel,” here.
How the Sackler Family Contributed to the Opioid Crisis
CW: Suicide, Addiction
PERDUE PHARMA $8 BIL SETTLEMENT
PERDUE PHARMA $8 BIL SETTLEMENT
PERDUE PHARMA $8 BIL SETTLEMENT
Purdue Pharma Reaches $8B Opioid Deal With Justice Department Over Oxycontin Sales
Purdue Pharma headquarters stands in downtown Stamford, April 2, 2019 in Stamford, Conn. Purdue Pharma, the maker of OxyContin, and its owners, the Sackler family, have faced hundreds of lawsuits for the company’s alleged role in the opioid epidemic that has killed more than…
View On WordPress
The US government secured a criminal conviction against Purdue Pharma in the mid-2000s but failed to curb sales of the drug after Giuliani reached a deal to avoid a bar on Purdue doing business.
The US government missed the opportunity to curb sales of the drug that kickstarted the opioid epidemic when it secured the only criminal conviction against the maker of OxyContin a decade ago.
Purdue Pharma hired Rudolph Giuliani, the former New York mayor and now Donald Trump’s lawyer, to head off a federal investigation in the mid-2000s into the company’s marketing of the powerful prescription painkiller at the centre of an epidemic estimated to have claimed at least 300,000 lives.
Chris McGreal, writing for The Guardian, looks at a criminal conviction against premiere drug-maker Purdue Pharma, in a story that will make you sick.